Breath Analyzer for Viral Respiratory Infection

This trial aims to determine if the MBP® Breath Analyzer can detect differences in breath patterns between children with respiratory illnesses and those without. Children aged 7 to 17 who have symptoms like fever, cough, or a runny nose might be suitable candidates. Those without these symptoms, visiting the emergency room for minor injuries, can also participate. Participants will breathe normally into the device for about a minute. The study will assess the device's effectiveness in identifying respiratory infections through breath analysis. As an unphased trial, this study provides a unique opportunity to contribute to innovative research that may enhance diagnostic tools for respiratory illnesses.

Research on the MBP® Breath Analyzer hasn't yet provided specific safety details. However, this device is non-invasive, meaning it doesn't enter the body. Participants simply breathe into it for about a minute. The trial is labeled "Not Applicable" for phases, indicating a focus on testing the device's effectiveness rather than its safety.

Researchers are excited about the MBP® Breath Analyzer trial because it offers a completely new way to detect viral respiratory infections. Unlike traditional methods, which rely on swabs or blood tests, this breath analyzer is non-invasive and quick, providing results by simply analyzing a breath sample. This could make diagnosing respiratory illnesses faster and more comfortable, especially for kids who might find other tests scary or uncomfortable. By comparing breath samples from children with symptoms to those without, researchers hope to refine this tool for easy and rapid diagnosis in emergency settings.

Research has shown that analyzing breath can help identify respiratory infections by detecting certain chemicals. In this trial, the MBP® Breath Analyzer will detect these chemicals, which may change during an infection. Participants in the Acute Respiratory Illness Group will provide breath samples to test the device's effectiveness in identifying infections. Meanwhile, the Healthy Control Group will provide breath samples to help differentiate between healthy individuals and those with respiratory illnesses. Although specific data on this device's effectiveness is not yet available, similar technologies have shown promise in distinguishing healthy individuals from those with respiratory illnesses. This suggests that the breath analyzer might spot infections by examining unique chemical patterns in breath samples. Early results from similar studies support the idea that breath analysis can be a useful tool for detecting respiratory issues.⁶⁷⁸⁹¹⁰